Appropriate treatment for stage 1 and 2 HER 2 positive and triple-negative breast cancer by immigration status in Ontario, Canada.
Abstract
e12511 Background: This study explored the appropriateness of treatment received for stages 1 and 2 HER2-positive and triple-negative (TNBC) breast cancer (BC) patients with subtypes between immigrants and long-term residents. Methods: We identified women aged 18 – 75 years in the Immigration, Refugee, and Citizenship Canada Permanent Resident (CIC) database diagnosed with BC in Ontario from 2012-2019 and matched each to two long-term residents and linked to population-wide treatment databases. We categorized them into four mutually exclusive groups based on subtype (Her-2 positive vs triple negative) and breast surgery (breast-conserving surgery (BCS) vs mastectomy). Appropriate treatment included chemotherapy for all, (plus Herceptin if Her-2 overexpressing), plus breast radiation therapy if breast-conserving surgery was performed. We could not assess the receipt of endocrine therapy for the hormone receptor-positive subset of Her-2 overexpressors or indications for post-mastectomy radiation therapy. Odds ratios for receiving appropriate treatment were calculated using logistic regression adjusting for age, resource utilization and residential ethnicity concentration. Results: The analysis included 8490 women, 1538 immigrants, and 6952 long-term resident women who had a follow-up over one year. The mean age of immigrants (50.10(SD9.8)) was lower than long-term residents (54.70(SD11.13)) (p < 0.0001). Conclusions: Immigration status did not affect the receipt of appropriate treatment amongst early-stage breast cancer patients with Her2 positive or triple-negative breast cancer patients treated with either breast-conserving surgery or mastectomy in Ontario. Receipt of treatment for stages 1&2, HER2 + and triple-negative, breast cancer on adjusted analysis. Her2+ patients Breast-Conserving Surgery Mastectomy Adjusted odds Ratio 95%CL(p-value) Adjusted odds Ratio 95%CL(p-value) Immigrants vs long-term residents 0.82ref 0.65-1.04(0.09)ref 0.95ref 0.67-1.35(0.79)ref Triple Negative patients Breast-conserving Surgery Mastectomy Adjusted Odds Ratio 95%CL(p-value) Adjusted Odds Ratio 95%CL(p-value) Immigrants vs long-term residents 0.81ref 0.58-1.13(0.22)ref 0.85ref 0.49-1.46(0.55)ref
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (6)
Lawrence Frank Paszat
Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
Omolara Aminat Fatiregun
Lagos State University College of Medicine/Teaching Hospital, Lagos, Lagos, Nigeria
Rinku Sutradhar
5ICES, Toronto, Canada
Sho Podolsky
3Institute for Clinical Evaluative Sciences, Toronto, Canada
Andrea Eisen
Department of Medical Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, ON, Canada
Eileen Rakovitch
Sunnybrook Health Sciencies, Toronto, ON, Canada